Intestinal Permeability Biomarkers for Predicting Cardiometabolic Risk in Type 2 Diabetes Mellitus
Nutrients · 2026
DOI: 10.3390/nu18010167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Nursel Dal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Faculty of Health Sciences, Bandirma Onyedi Eylul University, Balikesir 10250, Türkiye. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Cardiometabolic Risk Factors, Intestinal Mucosa. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gazi University, Gazi University Scientific Research Projects Unit.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes can increase cardiovascular risk (CVR) through hyperglycemia and intestinal damage. The purpose of this study is to evaluate several intestinal permeability biomarkers in predicting CVR in patients with type 2 diabetes mellitus (T2DM).
Methods
This study was conducted in 2024 with a total of 70 patients with T2DM, aged 19–64 years (32.9% men, 67.1% women). Socio-demographic data and health status were collected; Framingham Risk Score (FRS), anthropometric measures, and serum parameters (glucose, HbA1c, lipids, CRP, TNF-α, IL-6, trimetilamine-N-oxide (TMAO), zonulin, intestinal fatty acid binding protein (I-FABP)) were evaluated, and visceral adiposity index (VAI) and plasma atherogenic index (PAI) were calculated.
Results
The mean age of patients (n = 70) was 55.0 ± 7.55 years. According to FRS, 18.5% of individuals were determined to be at medium–high CVR; a positive correlation was found between BMI, waist–height ratio, body fat ratio, VAI value, and FRS total score (p < 0.05). Serum TMAO, zonulin, and I-FABP levels did not differ between low-risk and medium–high-risk patients (p > 0.05). Serum TMAO, zonulin, and I-FABP levels were positively correlated with TNF-α and IL-6 levels, and serum TMAO and I-FABP levels were positively correlated with triglyceride levels (p < 0.05). Moreover, serum zonulin and I-FABP levels were positively correlated with PAI (p < 0.05).
Conclusions
Abdominal obesity and intestinal permeability may affect inflammatory processes and blood lipids in patients with T2DM. Further studies with large samples are needed to examine dietary factors related to the relationship between intestinal permeability and cardiometabolic risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Dietetics, Faculty of Health Sciences, Bandirma Onyedi Eylul University, Balikesir 10250, Türkiye.
- Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Ankara 06560, Türkiye.
- Interrnal Medicine Specialist, Ministry of Health Torbali State Hospital, İzmir 35860, Türkiye.
- Department of Nutrition and Dietetics, Faculty of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Türkiye.
ORCID-Profile: Nursel Dal, Saniye Bilici, Perim Fatma Turker
Förderung
- Gazi University
- Gazi University Scientific Research Projects Unit
Zitieren
APA
Dal, N., Bilici, S., Akin, S., & Turker, P. F. (2026). Intestinal Permeability Biomarkers for Predicting Cardiometabolic Risk in Type 2 Diabetes Mellitus. Nutrients. https://doi.org/10.3390/nu18010167
Vancouver
Dal N, Bilici S, Akin S, Turker PF. Intestinal Permeability Biomarkers for Predicting Cardiometabolic Risk in Type 2 Diabetes Mellitus. Nutrients. 2026. doi:10.3390/nu18010167
BibTeX
@article{Dal2026,
author = {Dal, Nursel and Bilici, Saniye and Akin, Sirin and Turker, Perim Fatma},
title = {Intestinal Permeability Biomarkers for Predicting Cardiometabolic Risk in Type 2 Diabetes Mellitus},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18010167}
}
EUVIMED